The mission of ALDEA Pharmaceuticals is to improve patients’ health using a novel platform of enzyme activators as drugs. These drugs, called Aldas (for Aldehyde Dehydrogenase Activators), enhance the removal of acetaldehyde and other toxic aldehydes that induce many oxidative stress associated diseases by impairing the function of proteins and inducing mutations in DNA.

This novel and proprietary technology originated from Stanford University and was published in top tier scientific journals (Science, 2008; Nature Structural and Molecular Biology, 2010; Science Translational Medicine, 2011). The potential and efficacy of Aldas have been demonstrated in many animal models of human diseases.

PLEASE CONTACT US FOR MORE INFORMATION: